Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,127.20
(
0.47%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.27
(
-1.38%
)
Bitcoin
74,006.10
(
0.09%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rwdm post# 126727

Tuesday, 09/20/2011 8:18:22 AM

Tuesday, September 20, 2011 8:18:22 AM

Post# of 257253
Yet another clueless blog from Seeking Alpha:

http://seekingalpha.com/article/294659-merck-s-curious-ms-acquisition-was-a-gamble-worth-taking

Merck's Curious MS Acquisition Was A Gamble Worth Taking

The odds may be extremely long, but when the wager is just $1.5m for a phase II-ready product in a major therapeutic area, it may just be worth a flutter. That could be the thinking behind Merck KGaA’s (MRK) decision to acquire PI-2301 from the bankrupt debris of Peptimmune…

Merck KGaA is not MRK. LMAO

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now